Jimmy Choo shares surge as first-half revenue jumps, Entertainment One plunges.
Technical evidence shows bigger issues are at play at the EpiPen maker.
The pharmaceutical company announced that it will increase its patient assistance program in hopes of quelling a growing backlash over its drug pricing.
With a new Zika case now confirmed on Florida's East Coast, here's four stocks investors should consider as concerns about the virus reach an all-time high
Short-seller Andrew Left says Mallinckrodt has long been gaming the system on its Acthar Gel drug.
U.S. stocks moved slightly lower on Thursday as investors anxiously await remarks from Federal Reserve Chair Janet Yellen on Friday.
Charles Schwab has a new target in the battle for your retirement dollars.
An Amgen drug to treat secondary hyperparathyroidism was rejected by U.S. regulators Wednesday but the biotech company offered no public explanation for why the drug's marketing application was denied.
The pharma company has been increasing the price of the epinephrine injector since 2007, so why are people finally taking notice?
U.S. stock losses grew heavier Wednesday as the afternoon wore-on with a selloff in crude oil and health care stocks leading Wall Street into the red.
Shares of the world's second largest generic pharma company fell nearly 5% after U.S. politicians target company for price gouging.
The Nasdaq Biotechnology Index fell 3.5% heading into Wednesday's close, with the loss triggered by a statement from Clinton's presidential campaign blasting Mylan for 'outrageous' pricing of the EpiPen.
Shares of the pharmaceutical company were climbing Wednesday on news of a $16.6 million contract awarded.
The pharmaceutical giant says it has inked a deal for the development rights of some growing antibiotics businesses.
The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.